118 related articles for article (PubMed ID: 11243422)
21. Relationship of left ventricular systolic function to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the development of new heart failure.
Okin PM; Wachtell K; Gerdts E; Dahlöf B; Devereux RB
J Hypertens; 2014 Dec; 32(12):2472-8; discussion 2478. PubMed ID: 25340854
[TBL] [Abstract][Full Text] [Related]
22. The role of angiotensin receptor-1 blockade on electromechanical changes induced by left ventricular hypertrophy and its regression.
Gray RP; Turner MA; Sheridan DJ; Fry CH
Cardiovasc Res; 2007 Feb; 73(3):539-48. PubMed ID: 17174288
[TBL] [Abstract][Full Text] [Related]
23. Influence of diabetes on efficacy of aliskiren, losartan or both on left ventricular mass regression.
Vardeny O; Pouleur AC; Takeuchi M; Appelbaum E; Verma A; Prescott M; Smith B; Dahlof B; Solomon SD;
J Renin Angiotensin Aldosterone Syst; 2012 Jun; 13(2):265-72. PubMed ID: 22415888
[TBL] [Abstract][Full Text] [Related]
24. Long-term treatment of spontaneously hypertensive rats with losartan and electrophysiological remodeling of cardiac myocytes.
Cerbai E; Crucitti A; Sartiani L; De Paoli P; Pino R; Rodriguez ML; Gensini G; Mugelli A
Cardiovasc Res; 2000 Jan; 45(2):388-96. PubMed ID: 10728359
[TBL] [Abstract][Full Text] [Related]
25. Effects of losartan on left ventricular mass: a three-year follow-up in elderly hypertensives with myocardial hypertrophy despite successful conventional antihypertensive treatment.
Moroni C; Tolone S; Lopreiato F; Scrofani AR; Bossini A; Affricano C; Cassone R; Gaudio C
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1323-1328. PubMed ID: 28387895
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease.
Shibasaki Y; Masaki H; Nishiue T; Nishikawa M; Matsubara H; Iwasaka T
Nephron; 2002 Mar; 90(3):256-61. PubMed ID: 11867945
[TBL] [Abstract][Full Text] [Related]
27. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H
Am J Hypertens; 1997 Jul; 10(7 Pt 1):705-13. PubMed ID: 9234823
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis.
Weinberg EO; Lee MA; Weigner M; Lindpaintner K; Bishop SP; Benedict CR; Ho KK; Douglas PS; Chafizadeh E; Lorell BH
Circulation; 1997 Mar; 95(6):1592-600. PubMed ID: 9118530
[TBL] [Abstract][Full Text] [Related]
29. Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients.
Okin PM; Hille DA; Kjeldsen SE; Lindholm LH; Edelman JM; Dahlöf B; Devereux RB
Am J Hypertens; 2010 Jul; 23(7):786-93. PubMed ID: 20395941
[TBL] [Abstract][Full Text] [Related]
30. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study.
Bang CN; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Roman MJ; Køber L; Wachtell K; Devereux RB
J Hypertens; 2013 Oct; 31(10):2060-8. PubMed ID: 23838656
[TBL] [Abstract][Full Text] [Related]
31. Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart.
Rials SJ; Wu Y; Ford N; Pauletto FJ; Abramson SV; Rubin AM; Marinchak RA; Kowey PR
Circulation; 1995 Jan; 91(2):426-30. PubMed ID: 7805247
[TBL] [Abstract][Full Text] [Related]
32. Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients.
Okin PM; Devereux RB; Harris KE; Jern S; Kjeldsen SE; Julius S; Edelman JM; Dahlöf B;
Ann Intern Med; 2007 Sep; 147(5):311-9. PubMed ID: 17785486
[TBL] [Abstract][Full Text] [Related]
33. Regression of left ventricular hypertrophy by AT1 receptor blockade in renal transplant recipients.
Klingbeil AU; Müller HJ; Delles C; Fleischmann E; Schmieder RE
Am J Hypertens; 2000 Dec; 13(12):1295-300. PubMed ID: 11130774
[TBL] [Abstract][Full Text] [Related]
34. Hypomethylation of Agtrap is associated with long-term inhibition of left ventricular hypertrophy in prehypertensive losartan-treated spontaneously hypertensive rats.
Wang TJ; Lian GL; Lin X; Zhong HB; Xu CS; Wang HJ; Xie LD
Mol Med Rep; 2017 Feb; 15(2):839-846. PubMed ID: 28000857
[TBL] [Abstract][Full Text] [Related]
35. Improvement of cardiac diastolic function by long-term centrally mediated sympathetic inhibition in one-kidney, one-clip hypertensive rabbits.
Signolet IL; Bousquet PP; Monassier LJ
Am J Hypertens; 2008 Jan; 21(1):54-60. PubMed ID: 18091744
[TBL] [Abstract][Full Text] [Related]
36. The electrophysiology of rabbit hearts with left ventricular hypertrophy under normal and ischaemic conditions.
Hicks MN; McIntosh MA; Kane KA; Rankin AC; Cobbe SM
Cardiovasc Res; 1995 Aug; 30(2):181-6. PubMed ID: 7585803
[TBL] [Abstract][Full Text] [Related]
37. The importance of left ventricular hypertrophy in human hypertension.
Kahan T
J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
[TBL] [Abstract][Full Text] [Related]
38. Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonists: a comparison of lisinopril and losartan.
Akinboboye OO; Chou RL; Bergmann SR
J Am Coll Cardiol; 2002 Aug; 40(4):703-9. PubMed ID: 12204500
[TBL] [Abstract][Full Text] [Related]
39. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Dahlöf B
Hypertension; 2000 Nov; 36(5):766-73. PubMed ID: 11082141
[TBL] [Abstract][Full Text] [Related]
40. Acute effects of angiotensin II receptor antagonist on autoregulation of zonal glomerular filtration rate in renovascular hypertensive rats.
Wang X; Aukland K; Iversen BM
Kidney Blood Press Res; 1997; 20(4):225-32. PubMed ID: 9398027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
